The SERPERA Bone Marrow Blood Cell Separator has obtained the medical device license from the Taiwan Food and Drug Administration(TFDA).
- design sensation
- Oct 7, 2022
- 1 min read
USH Inc. product, the SERPERA Bone Marrow Blood Cell Separator, received the TFDA medical device license (License Number: 007571) on October 7, 2022. Sales of the product will commence in November.